Skip to main content
SpringerLink
Log in

The Psychosocial Burden of Psoriasis

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background: Skin diseases such as psoriasis can profoundly influence a patient’s self-image, self-esteem, and sense of well-being. Psoriasis is a multifactorial inflammatory condition with a disease burden that extends beyond the physical symptoms experienced by patients. Psoriasis affects all aspects of quality of life, including physical, psychologic, social, sexual, and occupational elements.

Objective: The goal of this article was to review the published literature on the impact of psoriasis on quality of life.

Methods: Relevant studies were identified through a comprehensive search of MEDLINE, EMBASE, and the Derwent Drug File databases of English-language articles published between 1993 and 2005 using the terms psoriasis in combination with quality of life, cost, cost-benefit analysis, economic, employment, days lost, healthcare, hospitalization, managed care, outcomes research, occupation, payers, and psychosocial. The reference lists of identified articles were checked for additional studies that might have been missed in the original searches.

Results: Data suggest that social stigmatization, high stress levels, physical limitations, depression, employment problems and other psychosocial co-morbidities experienced by patients with psoriasis are not always proportional to, or predicted by, other measurements of disease severity such as body surface area involvement or plaque severity.

Conclusion: It is essential to include measures of psychosocial morbidity when assessing psoriasis severity and treatment efficacy because of the substantial role that psychosocial burden plays in patient perception of disease severity, quality of life, and disease course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med. 1995; 332 (9): 581–8

    Article  PubMed  CAS  Google Scholar 

  2. Elder IT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol. 2001; 137 (11): 1447–54

    PubMed  CAS  Google Scholar 

  3. Ameen M. Genetic basis of psoriasis vulgaris and its pharmacogenetic potential. Pharmacogenomics. 2003; 4 (3): 297–308

    Article  PubMed  CAS  Google Scholar 

  4. Prinz JC. The role of T cells in psoriasis. J Fur Acad Dermatol Venereol. 2003; 17 (3): 257–70

    Article  CAS  Google Scholar 

  5. Javitz HS, Ward MM, Farber E, et al. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002; 46 (6): 850–60

    Article  PubMed  Google Scholar 

  6. Stern RS. Inpatient hospital care for psoriasis: a vanishing practice in the United States. J Am Acad Dermatol. 2003; 49 (3): 445–50

    Article  PubMed  Google Scholar 

  7. National Psoriasis Foundation Data, 2004 [online]. Available from URL: http://www.psoriasis.org [Accessed 2004 May 26]

  8. National Institute of Arthritis and Musculoskeletal and Skin Diseases data, 2003 May [online]. Available from URL: http://www.miams.nih.gov/hi/topics/psoriasis/psoriafs.htm [Accessed 2004 May 26]

  9. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985; 13 (3): 450–6

    Article  PubMed  CAS  Google Scholar 

  10. Ferrandiz C, Pujol RM, Garcia-Patos V, et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002; 46 (6): 867–73

    Article  PubMed  Google Scholar 

  11. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002; 47 (4): 512–8

    Article  PubMed  Google Scholar 

  12. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001; 137 (3): 280–4

    PubMed  CAS  Google Scholar 

  13. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995; 32 (6): 982–6

    Article  PubMed  CAS  Google Scholar 

  14. Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn’s disease. J Am Acad Dermatol. 2003; 48 (6): 805–21

    Article  PubMed  Google Scholar 

  15. Wahl A, Loge JH, Wiklund I, et al. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol. 2000; 43 (5 Pt 1): 803–8

    Article  PubMed  CAS  Google Scholar 

  16. Krueger GG, Feldman SR, Camisa C, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?. J Am Acad Dermatol. 2000; 43 (2 Pt 1): 281–5

    Article  PubMed  CAS  Google Scholar 

  17. Perrott SB, Murray AH, Lowe J, et al. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000; 70 (5): 567–71

    Article  PubMed  CAS  Google Scholar 

  18. Richards HL, Fortune DG, Griffiths CE, et al. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001; 50 (1): 11–5

    Article  PubMed  CAS  Google Scholar 

  19. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol. 2002; 146 (6): 1006–16

    Article  PubMed  CAS  Google Scholar 

  20. Touw CR, Hakkaart-Van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol. 2001; 144 (5): 967–72

    Article  PubMed  CAS  Google Scholar 

  21. Chren MM. Understanding research about quality of life and other health outcomes. J Cutan Med Surg. 1999; 3 (6): 312–6

    PubMed  CAS  Google Scholar 

  22. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermalot. 1999; 140 (5): 887–90

    Article  CAS  Google Scholar 

  23. Wahl A, Mourn T, Hanestad BR, et al. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res. 1999; 8 (4): 319–26

    Article  PubMed  CAS  Google Scholar 

  24. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999; 41 (3 Pt 1): 401–7

    Article  PubMed  CAS  Google Scholar 

  25. Kirby B, Fortune DG, Bhushan M, et al. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol. 2000; 142 (4): 728–32

    Article  PubMed  CAS  Google Scholar 

  26. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003; 1 (1): 29

    Article  PubMed  Google Scholar 

  27. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996; 14 (3): 485–96

    Article  PubMed  CAS  Google Scholar 

  28. Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol 2003; 49 (2 Suppl.): S57–61

    Article  PubMed  Google Scholar 

  29. Koo J, Kozma CM, Reinke K. The development of a disease-specific questionnaire to assess the quality of life for psoriasis patients: an analysis of the reliability, validity, and responsiveness of the psoriasis quality of life questionnaire. Dermatol Psychosom. 2002; 3: 171–9

    Article  Google Scholar 

  30. Koo J, Kozma CM, Menter A, Lebwohl M. Development of the 12 item psoriasis quality of life questionnaire (PQOL) [poster no. 606]. 61 st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21–26; San Francisco (CA)

    Google Scholar 

  31. Jenner N, Campbell J, Plunkett A, et al. Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol. 2002; 43 (4): 255–61

    Article  PubMed  Google Scholar 

  32. McHenry PM, Doherty VR. Psoriasis: an audit of patients’ views on the disease and its treatment. Br J Dermatol. 1992; 127 (1): 13–7

    Article  PubMed  CAS  Google Scholar 

  33. Root S, Kent G, al-Abadie MS. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology. 1994; 189 (3): 234–7

    Article  PubMed  CAS  Google Scholar 

  34. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000; 143 (5): 969–73

    Article  PubMed  CAS  Google Scholar 

  35. Fortune DG, Richards HL, Main CJ, et al. What patients with psoriasis believe about their condition. J Am Acad Dermatol. 1998; 39 (2 Pt 1): 196–201

    Article  PubMed  CAS  Google Scholar 

  36. Rapp SR, Exum ML, Reboussin DM, et al. The physical, psychological and social impact of psoriasis. J Health Psychol. 1997; 2: 525–37

    Article  PubMed  CAS  Google Scholar 

  37. Rapp SR, Feldman SR, Fleischer AB, et al. Health-related quality of life in psoriasis: a biopsychosocial model and measures. In: Rajagopalan R, Sherertz E, Anderson R, editors. Care and management of skin diseases: life quality and economic impact. New York: Marcel Dekker,; 1998: 125–45

    Google Scholar 

  38. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995; 75 (3): 240–3

    PubMed  CAS  Google Scholar 

  39. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. 1994; 56 (1): 36–40

    PubMed  CAS  Google Scholar 

  40. Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res. 2002; 12 (2): 250–61

    Article  PubMed  Google Scholar 

  41. Pettey AA, Balkrishnan R, Rapp SR, et al. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003; 49 (2): 271–5

    Article  PubMed  Google Scholar 

  42. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995; 132 (2): 236–44

    Article  PubMed  CAS  Google Scholar 

  43. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol. 1987; 12 (1): 8–11

    Article  PubMed  CAS  Google Scholar 

  44. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990; 123 (6): 751–6

    Article  PubMed  CAS  Google Scholar 

  45. de Jong EM, Seegers BA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology. 1996; 193 (4): 300–3

    Article  PubMed  Google Scholar 

  46. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations: data from the Nordic Quality of Life Study. Acta Derm Venereol. 2002; 82 (2): 108–13

    Article  PubMed  Google Scholar 

  47. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80 (6): 430–4

    Article  PubMed  CAS  Google Scholar 

  48. Gladman DD, Rahman P. Psoriatic arthritis. In: Ruddy S, Harris ED, Sledge CB, et al., editors. Kelley’s textbook of rheumatology. 6th ed. Philadelphia (PA): WB Saunders Company,. 2001: 1071–8

    Google Scholar 

  49. Baughman RD, Sobel R. Psoriasis: a measure of severity. Arch Dermatol; 1970; 101 (4): 390–5

    Article  PubMed  CAS  Google Scholar 

  50. Schmid-Ott G, Jaeger B, Kuensebeck HW, et al. Dimensions of stigmatization in patients with psoriasis in a ‘Questionnaire on Experience with Skin Complaints’. Dermatology; 1996; 193 (4): 304–10

    Article  PubMed  CAS  Google Scholar 

  51. Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993; 32 (8): 587–91

    Article  PubMed  CAS  Google Scholar 

  52. Fried RG, Friedman S, Paradis C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol. 1995; 34 (2): 101–5

    Article  PubMed  CAS  Google Scholar 

  53. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 1998; 61 (6): 339–42

    PubMed  CAS  Google Scholar 

  54. Vardy D, Besser A, Amir M, et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002; 147 (4): 736–42

    Article  PubMed  CAS  Google Scholar 

  55. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol. 1995; 34 (10): 700–3

    Article  PubMed  CAS  Google Scholar 

  56. Akay A, Pekcanlar A, Bozdag KE, et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Fur Acad Dermatol Venereol. 2002; 16 (4): 347–52

    Article  CAS  Google Scholar 

  57. Fortune DG, Main CJ, O’Sullivan TM, et al. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res. 1997; 42 (5): 467–75

    Article  PubMed  CAS  Google Scholar 

  58. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Fur Acad Dermatol Venereol. 2000; 14 (4): 267–71

    Article  CAS  Google Scholar 

  59. Nyfors A, Lemholt K. Psoriasis in children: a short review and a survey of 245 cases. Br J Dermatol. 1975; 92 (4): 437–42

    Article  PubMed  CAS  Google Scholar 

  60. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol. 1997; 36 (4): 259–62

    Article  PubMed  CAS  Google Scholar 

  61. Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol. 1988; 118 (2): 195–201

    Article  PubMed  CAS  Google Scholar 

  62. de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001; 144 Suppl. 58: 33–6

    Google Scholar 

  63. Feldman SR, Fleischer Jr AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 1997; 37 (4): 564–9

    Article  PubMed  CAS  Google Scholar 

  64. Fortune DG, Main CJ, O’Sullivan TM, et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997; 137 (5): 755–60

    Article  PubMed  CAS  Google Scholar 

  65. Fleischer Jr AB, Feldman SR, Bradham DD. Office-based physician services provided by dermatologists in the United States in 1990. J Invest Dermatol. 1994; 102 (1): 93–7

    Article  PubMed  Google Scholar 

  66. Gelfand JM, Berlin J, Van Voorhees A, et al. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol. 2003; 139 (11): 1425–9

    Article  PubMed  Google Scholar 

  67. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998; 139 (5): 846–50

    Article  PubMed  CAS  Google Scholar 

  68. Hardy GE, Cotterill JA. A study of depression and obsessionality in dysmorphophobic and psoriatic patients. Br J Psychiatry. 1982; 140: 19–22

    Article  PubMed  CAS  Google Scholar 

  69. Scharloo M, Kaptein AA, Weinman J, et al. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol. 2000; 142 (5): 899–907

    Article  PubMed  CAS  Google Scholar 

  70. Farber EM, Nall L. Psoriasis and alcoholism. Cutis. 1994; 53 (1): 21–7

    PubMed  CAS  Google Scholar 

  71. Wolf R, Wolf D, Ruocco V. Alcohol intake and psoriasis. Clin Dermatol. 1999; 17 (4): 423–30

    Article  PubMed  CAS  Google Scholar 

  72. Higgins EM, du Vivier AW. Alcohol abuse and treatment resistance in skin disease [letter]. J Am Acad Dermatol. 1994; 30 (6): 1048

    Article  PubMed  CAS  Google Scholar 

  73. Higgins EM, du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull. 1994; 50 (1): 85–98

    PubMed  CAS  Google Scholar 

  74. Higgins EM, du Vivier AW. Alcohol and the skin. Alcohol Alcohol. 1992; 27 (6): 595–602

    PubMed  CAS  Google Scholar 

  75. Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol. 1993; 28 (5 Pt 1): 730–2

    Article  PubMed  CAS  Google Scholar 

  76. Vincenti GE, Blunden SM. Psoriasis and alcohol abuse. J R Army Med Corps. 1987; 133 (2): 77–8

    PubMed  CAS  Google Scholar 

  77. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol. 1999; 135 (12): 1490–3

    Article  PubMed  CAS  Google Scholar 

  78. Gottlieb AB. Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov. 2005; 4 (1): 19–34

    Article  PubMed  CAS  Google Scholar 

  79. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005; 64 Suppl. 2: ii83–6

    Article  Google Scholar 

  80. Salek MS, Finlay AY, Lewis JJ, et al. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res. 2004; 13 (1): 91–5

    Article  PubMed  CAS  Google Scholar 

  81. Ellis CN, Mordin MM, Adler EY. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial. Am J Clin Dermatol. 2003; 4 (2): 131–9

    Article  PubMed  Google Scholar 

  82. Feldman SR, Menter A, Koo JY. Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis. Br J Dermatol. 2004; 150 (2): 317–26

    Article  PubMed  CAS  Google Scholar 

  83. Ricardo RR, Rhoa M, Orenberg EK, et al. Clinical benefits in patients with psoriasis after efalizumab therapy: clinical trials versus practice. Cutis. 2004; 74 (3): 193–200

    PubMed  Google Scholar 

  84. Nijsten T, Margolis DJ, Feldman SR, et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol. 2005; 52 (3 Pt 1): 434–44

    Article  PubMed  Google Scholar 

  85. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004; 51 (2): 212–6

    Article  PubMed  Google Scholar 

  86. Richards HL, Fortune DG, O’Sullivan TM, et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999; 41 (4): 581–3

    PubMed  CAS  Google Scholar 

  87. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004; 140 (4): 408–14

    Article  PubMed  Google Scholar 

  88. Carroll CL, Feldman SR, Camacho FT, et al. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004; 151 (4): 895–7

    Article  PubMed  CAS  Google Scholar 

  89. Fortune DG, Richards HL, Kirby B, et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002; 146 (3): 458–65

    Article  PubMed  CAS  Google Scholar 

  90. Richards HL, Fortune DG, Weidmann A, et al. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol. 2004; 151 (6): 1227–33

    Article  PubMed  CAS  Google Scholar 

  91. Seng TK, Nee TS. Group therapy: a useful and supportive treatment for psoriasis patients. Int J Dermatol. 1997; 36 (2): 110–2

    Article  PubMed  CAS  Google Scholar 

  92. Zachariae R, Oster H, Bjerring P, et al. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol. 1996; 34 (6): 1008–15

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Alexa Kimball serves on the advisory board for Centocor, Inc.

The authors wish to thank Tanya Aynessazian, and her colleagues at Ovation Research Group and Centocor, Inc., for research support for this project. Additionally, the authors would like to acknowledge Carol Lewis, PhD for her editorial support in the development of this manuscript.

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, Massachusetts, USA

    Alexa B. Kimball

  2. Stanford University School of Medicine, Stanford, California, USA

    Christine Jacobson

  3. Kaiser Permanente Medical Center, Stockton, California, USA

    Stefan Weiss

  4. Ovation Research Group, Highland Park, Illinois, USA

    Mary G. Vreeland

  5. Centocor, Inc., Malvern, Pennsylvania, USA

    Ying Wu

Authors
  1. Alexa B. Kimball
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary G. Vreeland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ying Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexa B. Kimball.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimball, A.B., Jacobson, C., Weiss, S. et al. The Psychosocial Burden of Psoriasis. Am J Clin Dermatol 6, 383–392 (2005). https://doi.org/10.2165/00128071-200506060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200506060-00005

Keywords

Search

Navigation